SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ResMed Inc. – ‘8-K/A’ for 6/13/22 – ‘XML’

On:  Thursday, 8/11/22, at 8:57pm ET   ·   As of:  8/12/22   ·   For:  6/13/22   ·   Accession #:  1193125-22-218896   ·   File #:  1-15317

Previous ‘8-K’:  ‘8-K’ on / for 8/11/22   ·   Next:  ‘8-K’ on / for 10/27/22   ·   Latest:  ‘8-K’ on / for 4/25/24   ·   1 Reference:  To:  ResMed Inc. – ‘8-K’ on 6/14/22 for 6/13/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/22  ResMed Inc.                       8-K/A:7,8,9 6/13/22   10:159K                                   Donnelley … Solutions/FA

Amendment to Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     36K 
 5: R1          Document and Entity Information                     HTML     50K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- d387047d8ka_htm                     XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      9K 
 3: EX-101.LAB  XBRL Labels -- rmd-20220613_lab                      XML     57K 
 4: EX-101.PRE  XBRL Presentations -- rmd-20220613_pre               XML     36K 
 2: EX-101.SCH  XBRL Schema -- rmd-20220613                          XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
10: ZIP         XBRL Zipped Folder -- 0001193125-22-218896-xbrl      Zip     14K 


‘XML’   —   XBRL Instance — d387047d8ka_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="rmd-20220613.xsd" xlink:type="simple"/>
<context id="duration_2022-06-13_to_2022-06-13">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000943819 </identifier>
</entity>
<period>
<startDate> 2022-06-13 </startDate>
<endDate> 2022-06-13 </endDate>
</period>
</context>
<dei:EntityRegistrantName contextRef="duration_2022-06-13_to_2022-06-13" id="Hidden_dei_EntityRegistrantName"> RESMED INC </dei:EntityRegistrantName>
<dei:EntityAddressCountry contextRef="duration_2022-06-13_to_2022-06-13" id="Hidden_dei_EntityAddressCountry_duration_2022-06-13_to_2022-06-13"> US </dei:EntityAddressCountry>
<dei:AmendmentFlag contextRef="duration_2022-06-13_to_2022-06-13"> true </dei:AmendmentFlag>
<dei:EntityCentralIndexKey contextRef="duration_2022-06-13_to_2022-06-13" id="Hidden_dei_EntityCentralIndexKey"> 0000943819 </dei:EntityCentralIndexKey>
<dei:DocumentType contextRef="duration_2022-06-13_to_2022-06-13"> 8-K/A </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="duration_2022-06-13_to_2022-06-13"> 2022-06-13 </dei:DocumentPeriodEndDate>
<dei:EntityIncorporationStateCountryCode contextRef="duration_2022-06-13_to_2022-06-13"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="duration_2022-06-13_to_2022-06-13"> 001-15317 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="duration_2022-06-13_to_2022-06-13"> 98-0152841 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="duration_2022-06-13_to_2022-06-13"> 9001 Spectrum Center Blvd. </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="duration_2022-06-13_to_2022-06-13"> San Diego </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="duration_2022-06-13_to_2022-06-13"> CA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="duration_2022-06-13_to_2022-06-13"> 92123 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="duration_2022-06-13_to_2022-06-13"> (858) </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="duration_2022-06-13_to_2022-06-13"> 836-5000 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="duration_2022-06-13_to_2022-06-13"> Common Stock, $0.004 par value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="duration_2022-06-13_to_2022-06-13"> RMD </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="duration_2022-06-13_to_2022-06-13"> NYSE </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:EntityEmergingGrowthCompany>
<dei:AmendmentDescription contextRef="duration_2022-06-13_to_2022-06-13"> This amendment on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed by ResMed Inc. (“ResMed”) on June 14, 2022 (the “Original Report”) disclosing that on June 13, 2022 ResMed entered into a Sale and Purchase Agreement (the “Purchase Agreement”) with Mondstein 483. GmbH, a limited liability company under the laws of Germany and wholly-owned indirect subsidiary of ResMed and Miami Holding S.ŕ r.l., a limited liability company under the laws of the Grand Duchy of Luxembourg. This Amendment amends and restates the Original Report in its entirety by making the disclosure of the entering into the Purchase Agreement and related description of such Purchase Agreement an Item 8.01 Other Events disclosure rather than an Item 1.01 Entry into a Material Definitive Agreement disclosure as provided by the general instructions for the use of the Current Report on Form 8-K. The Original Report and this Amendment continue to speak as of the date of the Original Report, and the Company has not updated the disclosures contained herein or therein to reflect any events which occurred at a date subsequent to the filing of the Original Report. </dei:AmendmentDescription>
</xbrl>


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/14/22  ResMed Inc.                       8-K:1,7,9   6/13/22   12:6.7M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-22-218896   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 5:06:34.1pm ET